Background:
The utility and efficacy of novel materials in tissue regeneration and antimicrobial therapy are contingent upon the employment of either blood derivatives rich in platelets or platelet-poor-plasma (PPP). This effect is largely mediated by the increased or decreased concentration of platelets in the plasma. The current study aimed to analyze and evaluate the impact of platelet-rich (PRP) or PPP on inhibiting the growth of human pathogenic bacteria and compare their effects with those of chloramphenicol and penicillin.
Methods:
In the current comparative study, PRP–1 was generated using 1-step blood centrifugation method; whereas, for PRP–2 and PPP the 2-step centrifugation protocol was used. The antimicrobial activity of PRP–1, 2, and PPP were tested on
Staphylococcus aureus
,
Escherichia coli
,
Klebsiella pneumonia
,
Pseudomonas aeruginosa
,
Streptococcus agalactiae
,
Staphylococcus epidermidis
,
Shigella
sp. and
Serratia
sp. Well diffusion and serial micro-dilution methods were used for this purpose. Chloramphenicol and penicillin susceptibility were tested using the disk diffusion method.
Results:
While whole blood (WB) and PPP had no discernible impact on the growth parameters of any of the bacteria tested in the current study, PRP-1 reduced the growth rate of a few selected strains. In addition, while PRP-2 clearly inhibited the growth of
Shigella
sp.
, E. coli, S. aureus
,
S. agalactiae,
and
S. epidermidis
, it had no impact on the growth of
K. pneumoniae
,
P. aeruginosa,
and
Serratia
sp
Conclusion:
It can be claimed that there is a strong correlation between the concentration of platelets and the antibacterial activity of PRP.